What place for the whole brain radiotherapy with hippocampal-sparing?;Quelle place pour l'irradiation panencéphalique avec épargne des hippocampes?

Cancer/Radiotherapie

Volumn 17, Issue 5-6, 2013, Pages 419-423

  Truc, G ^a   Martin, E ^a   Mirjolet, C ^a   Chamois, J ^b   Petitfils, A ^a   Crehange G ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b CHP Saint Gregoire   (France)

Author keywords

Brain metastases; Hippocampal avoidance; Neurocognition; Whole brain radiotherapy

Indexed keywords

ABLATION THERAPY; BRAIN METASTASIS; BRAIN RADIATION; BRAIN SURGERY; BREAST CANCER; DIGESTIVE SYSTEM CANCER; HIPPOCAMPUS; HUMAN; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; STEREOTACTIC RADIOSURGERY;

BRAIN METASTASES; ÉPARGNE DES HIPPOCAMPES; HIPPOCAMPAL AVOIDANCE; MÉTASTASES CÉRÉBRALES; NEUROCOGNITION; RADIOTHÉRAPIE ENCÉPHALIQUE TOTALE; WHOLE BRAIN RADIOTHERAPY;

BRAIN NEOPLASMS; COGNITION DISORDERS; CRANIAL IRRADIATION; HIPPOCAMPUS; HUMANS; LIFE EXPECTANCY; ORGAN SPARING TREATMENTS; PATIENT SELECTION; RADIOTHERAPY DOSAGE;

EID: 84884351071     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.06.042     Document Type: Short Survey

References (39)

1. Scoccianti S., Ricardi U. Treatment of brain metastases: review of phase III randomized controlled trials. Radiother Oncol 2012, 102:168-179.
2. Li J., Bentzen S.M., Renschler M., Minesh P.M. Regression after whole-brain radiotherapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25:1260-1266.
3. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 1:157-165.
4. Brown J.M., Koong A.C. High-dose single-fraction radiotherapy: exploiting a new biology?. Int J Radiat Oncol Biol Phys 2008, 71:324-325.
5. Wefel J.S., Kayl A.E., Meyers C.A. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 2004, 90:1691-1696.
6. Meyers C.A., Brown P.D. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006, 24:1305-1309.
7. DeAngelis L.M.D.J., Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789-796.
8. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus sereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
9. Soffietti R., Kocher M., Abacioglu U.M., Villa S., Fauchon F., Baumert B.G., et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 2013, 1:65-72.
10. Sun A., Bae K., Gore E.M., Movsas B., Wong S.J., Meyers C.A., et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011, 29:279-286.
11. Welzel G., Fleckenstein K., Schaefer J., Hermann B., Kraus-Tiefenbacher U., Mai S.K., et al. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 2008, 72:1311-1318.
12. Soussain C., Ricard D., Fike J.R., Mazeron J.J., Psimaras D., Delattre J.Y. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374:1639-1651.
13. Tallet A., Dhermain F., Taillia H., Ricard D., Mornex F., Métellus P. Cognition and radiation therapy for brain metastases: a new paradigm to define. Bull Cancer 2013, 100:69-74.
14. Lemaire V., Koehl M., Le Moal M., Abrous D.N. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci 2000, 97:11032-11037.
15. Tofilon P.J., Fike J.R. The radioresponse of the central nervous system: a dynamic process. Radiat Res 2000, 153:357-370.
16. Taupin P., Gage F.H. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res 2002, 15:745-749.
17. Mizumatsu S., Monje M.L., Morhardt D.R., Rola R., Palmer T.D., Fike J.R. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 2003, 63:4021.
18. Raber J., Fan Y., Matsumori Y., Liu Z., Weinstein P.R., Fike J.R., et al. Irradiation attenuates neurogenesis and exacerbates ischemia-induced deficits. Ann Neurol 2004, 55:381-389.
19. Eriksson P.S., Perfilieva E., Björk-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 1998, 4:1313-1317.
20. Ghia A., Tome W.A., Thomas S., et al. Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys 2007, 68:971-977.
21. Gondi V., Tome W.A., Marsh J., Struck A., Ghia A., Turian J.V., et al. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 2010, 95:327-331.
22. Wan J.F., Zhang S.J., Wang L., Zhao K.L. Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270metastases in 488patients. J Radiat Res 2013, 54:285-291.
23. Mehta M.P., Rodrigus P., Terhaard C.H.J., Rao A., Suh J., Roa W., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003, 21:2529-2536.
24. Chera B.S., Amdur R.J., Patel P., Mendenhall W.M. A radiation oncologist's guide to contouring the hippocampus. Am J Clin Oncol 2009, 32:20-22.
25. Radiation Therapy Oncology Group (RTOG) RTOG 0933hippocampal atlas 2013, RTOG, Philadelphie, PA, [(accès le 15/7/13), document sur Internet]. http://www.rtog.org/CoreLab/ContouringAtlases/HippocampalSparing.aspx.
26. Gondi V., Tolakanahalli R., Mehta M.P., Tewatia D., Rowley H., Kuo J.S., et al. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:1244-1252.
27. Gutiérrez A.N., Westerly D.C., Tomé W.A., Jaradat H.A., Mackie T.R., Bentzen S.M., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007, 69:589-597.
28. Hsu F., Carolan H., Nichol A., Cao F., Nuraney N., Lee R., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2010, 76:1480-1485.
29. Gondi V., Hermann B.P., Mehta M.P., Tomé W.A. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 2012, 83:487-493.
30. Awad R., Fogarty G., Hong A., Kelly P., Ng D., Santos D., et al. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience. Radiat Oncol 2013, 8:62.
31. Nieder C., Spanne O., Mehta M.P., Grosu A.L., Geinitz H. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20years?. Cancer 2011, 117:2505-2512.
32. Sperduto P.W., Kased N., Roberge D., Xu Z., Shanley R., Luo X., et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012, 30:419-425.
33. Noël G., Simon J.M., Valéry C.A., Cornu P., Boisserie G., Ledu D., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002, 79:245-255.
34. Noël G., Valéry C.A., Boisserie G., Cornu P., Hasboun D., Simon J.M., et al. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 2004, 22:25-31.
35. Aupérin A., Arriagada R., Pignon J.P., Le Péchoux C., Gregor A., Stephens R.J., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999, 341:476-484.
36. Slotman B., Faivre-Finn C., Kramer G., Rankin E., Snee M., Hatton M., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664-672.
37. Le Péchoux C., Mohhkles H.A., Dhermain F. Present role of prophylactic cranial irradiation. Bull Cancer 2013, 100:35-43.
38. Braccini A.L., Azria D., Mazeron J.J., Mornex F., Jacot W., Metellus P., et al. Métastases cérébrales: quelle prise en charge en 2012?. Cancer Radiother 2012, 16:309-314.
39. Bonnette P. Cancers bronchiques non à petites cellules avec oligométastases: prise en charge chirurgicale à visée curative. Cancer Radiother 2012, 16:344-347.